Skip to content

Share Bazaar Alert: War, Oil & Fed Meeting Eye Next Moves

A cocktail of international conflict, energy market mayhem, investor outflows, and central bank intrigue sets the stage for Indian stocks' rollercoaster ride next week. Mumbai's bulls and bears will...

By News Analysis India · · Updated · 1 min read

A cocktail of international conflict, energy market mayhem, investor outflows, and central bank intrigue sets the stage for Indian stocks' rollercoaster ride next week. Mumbai's bulls and bears will hang on developments in the US-Israel-Iran war, crude dynamics, FII trends, and the Fed's March powwow.

Fed policymakers convene March 17-18, unveiling rate fate on the 18th. With oil aflame from war, this session carries extra freight, as markets parse for hints on taming inflation without stifling a fragile recovery.

Supply hiccups propelled crude 11% higher last week, a boon for producers but nightmare fuel for consumer nations like India. Price swings could dictate everything from rupee stability to industrial output, keeping traders awake.

Entering its third week, the US-Israel-Iran showdown escalated via Trump's Kharg Island strike threats—a nerve center for Iranian oil. Extended strife risks choking global supplies, hammering trade balances and corporate earnings worldwide.

FIIs dumped ₹52,704 crore from Indian stocks in early March, amplifying volatility and testing DII backstops. Their flow direction will be a key pulse-check on global risk hunger.

Last week's geopolitics-triggered tumble saw Sensex crater 5.52% (4,354.98 points), Nifty 5.31% (1,299.35 points), with BSE market cap slashed ₹20 lakh crore to ₹430 lakh crore—a whopping evaporation in days.

Auto sector tanked hardest (Nifty Auto -10.64%), joined by PSU Banks (-7.27%), Defence (-7.01%), Private Banks (-6.96%), Metals (-5.90%), Fin Services (-5.68%), Manufacturing (-5.60%), and Infra (-5.07%), as growth stocks got hammered.

Optimism hinges on Fed reassurance or conflict cooling, potentially lifting spirits. Yet, sticky oil and FII negativity counsel defensive stances—think pharma, FMCG—while awaiting pivotal cues.